Primidone.

Probenecid.

Procaine and Adrenaline Injection.

Prochlorperazine Maleate.

Prochlorperazine Tablets.

Prochlorperazine Methanesulphonate.

Prochlorperazine Injection.

Procyclidine Hydrochloride.

Proguanil Hydrochloride.

Promazine Hydrochloride.

Promazine Injection.

Promazine Tablets.

Promethazine Theoclate.

Promethazine Theoclate Tablets.

Propyl Gallate.

Propyl Hydroxybenzoate.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propylthiouracil.

Pyridostigmine Bromide.

Pyrimethamine.

Quillaia.

Rabies Antiserum.

Rabies Vaccine.

Schick Control.

Senna Leaf.

Sesame Oil.

Soda Lime.

Sodium Acetrizoate Injection.

Sodium Anoxynaphthonate.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Bicarbonate Injection.

Sodium Calciumedetate.

Sodium Chromate (51Cr) Injection.

Sodium Diatrizoate.

Sodium Diatrizoate Injection.

Sodium Fluoride.

Sodium Iodide (131I) Injection.

Sodium Iodide (131I) Solution.

Sodium Lauryl Sulphate.

Sodium Phosphate (32P) Injection.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsone Tablets.

Staphylococcus Antitoxin.

Stibophen.

Stibophen Injection.

Stramonium.

Sulphadimidine Sodium.

Sulphamethizole.

Sulphamethoxypyridazine.

Sulphasomidine.

Sulphasomidine Tablets.

Sulphobromophthalein Sodium.

Suramin.

Suramin Injection.

Suxamethonium Bromide.

Suxamethonium Chloride.

Testosterone.

Testosterone Phenylpropionate.

Testosterone Phenylpropionate Injection.

Tetrachloroethylene.

Tetrachloroethylene Capsules.

Thiambutosine.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thioridazine Hydrochloride.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Trichloroethylene.

Trifluoperazine Hydrochloride.

Tripelennamine Hydrochloride.

Tryparsamide.

Tryparsamide Injection.

Tuberculin, Old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B and Tetanus Vaccine.

Typhoid-Paratyphoid A, B, and C Vaccine.

Urethane.

Vinyl Ether.

Vitamin A Ester Concentrate.

Yellow Fever Vaccine.

SECOND SCHEDULE.

Regulation 10 (3).

Allowable Compounds (if any) or Certain Drugs or Medicinal Preparations.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Acrylic Resin ...................	—
Adrenaline Acid Tartrate, B. P. .......	—
Aluminium Powder, B.P.C. .........	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
Aluminium Hydroxide Gel Dried, B.P.	Aluminium Hydroxide Gel Dried B.P. with Magnesium Hydroxide B.P.C.
	Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P.

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
	Aluminium Hydroxide Gel Dried B.P. with Magnesium Carbonate B.P.
	Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.C.
	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Aluminium Hydroxide Gel Dried B.P.
	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Amphotericin B. ...............	Tetracycline with a buffering agent and Amphotericin B.
Ancurine Hydrochloride, B.P. .......	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Antazoline Sulphate..............	Antazoline Sulphate with Naphazoline Nitrate B.P.
Ascorbic Acid, B.P...............	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite....................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin Eye Drops.............	—
Benzol (Commercial).............	—
Betamethasone Disodium Phosphate	—
Betamethasone Phosphate..........	—
Calciferol Solution, B.P............	—
Calcium Lactobionate ............	Thenalidine with Calcium Lactobionate
Carbromal, B.P. ................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C. ..............	—
Chloramphenicol, B.P.	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Chlorhexidine Gluconate ..........	—
Chlorpheniramine Malcate, B.P. .....	—
Chlorpromazine Hydrochloride, B.P.	—
Chlortetracycline Hydrochloride, B.P.	—
Clemizole Tannate ..............	—
Cortisone Acetate, B.P. ...........	—
Cymogran ....................	—
Cyproheptadine Hydrochloride ......	—
Cyclizine Hydrochloride, B.P. ......	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide ............	—
Demethylchlortetracycline Hydrochloride, B.P.	—
Dexchlorpheniramine Maleate ......	—
Dextran .....................	Dextran with Dextrose B.P.
	Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.C.	—
Dienoestrol, B.P. ...............	—
Digoxin, B.P.	—
Dihydrostreptomycin Sulphate, B.P. 1958	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrotachysterol ..............	—
Diphenhydramine Hydrochloride, B.P.	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphtheria Vaccine, B.P. ..........	Diphtheria and Tetanus Vaccine B.P.
	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Dyflos, B.P.C. .................	—

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Ecothiopate Iodide ...............	—
Entsufon ......................	Hexachlorophane B.P. with Entsufon.
Ergotamine Tartrate, B.P. ...........	Ergotamine Tartrate B.P. with Caffeine B.P.
	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions .......	—
Ethosuximide ...................	—
Ferric Hydroxide ................	—
Ferrous Aminoacetosulphate .........	—
Ferrous Gluconate, B.P. ............	—
Ferrous Succinate ................	—
Framycetin Sulphate ..............	—
Galactomin ....................	—
Glucose Indicator ................	—
Gramicidin ....................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Hamamelis Dry Extract, B.P.C. .......	Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P.
Hexachlorophane, B.P. ............	Hexachlorophane B.P. with Entsufon
	Hexachlorophane B.P. with Lissapol
	Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P. ..............	—
Hydrocortisone Acetate, B.P. ........	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Ipecacuanha, B.P. ................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride .........	—
Levallorphan Tartrate, B.P. ..........	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol ......................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
	Hexachlorophane B.P. with Lissapol
Lofenalac .....................	—
Magnesium Bicarbonate Solution, B.P. 1948	—
Magnesium Chloride ..............	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride
	Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C.	—
Meclozine Hydrochloride, B.P. .......	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P. ..........	—
Mercuric Oxide Eye Ointment, B.P.C.	—
Methdilazine Hydrochloride .........	—
Methyl Glucamine ...............	Theophylline B.P. with Methyl Glucamine
Minafen ......................	—
Naphazoline Nitrate, B.P. ...........	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P. ...........	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
	Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
	Neomycin Sulphate B.P. with Kaolin B.P.
	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Neostigmine Methylsulphate B.P.	—
Nicotinamide, B.P. ...............	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

Second Schedule—continued.

Pharmaceutical Benefits	Allowable Compounds (if any).
Nitrofurantoin, B.P. .............	—
Nystatin, B.P. .................	Tetracycline with a buffering agent and Nystatin B.P.
Oleandomycin .................	Tetracycline with Oleandomycin
Oxytetracycline Hydrochloride, B.P.	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytocin ....................	—
Pancreatin Enzyme U.S.N.F. XI .....	—
Papaveretum, B.P.C. .............	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Paracetamol, B.P. ...............	—
Penicillin, Benethamine, B.P.C. .....	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P. ........	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P. ...........	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. Fortified Procaine Penicillin Injection B.P.
	Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)	—
Penicillin, Potassium, B.P. .........	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P. ..........	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
	Fortified Procaine Penicillin Injection B.P.
	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
	Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P. ...........	Penicillin, Benethamine B.P. with Procaine Penicillin and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P. .........	Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P.
Pertussis Vaccine, B.P. ...........	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P. .......	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
	Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Pheniramine Maleate, B.P. .........	—
Phenytoin ....................	—
Pipenzolate Methobromide .........	—
Piperazine Citrate, B.P. ...........	—
Pituitary (Posterior Lobe), Powdered, B.P.C.	—
Polymyxin B. Sulphate, B.P. .......	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
	Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
	Polymyxin B. Sulphate with Propylene Glycol and Acetic Acid
Prednisolone, B.P. ..............	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Methylprednisolone, B.P. ..........	—
Prednisolone Sodium Phosphate, B.P.C.	—
Prednisolone Trimethylacetate, B.P.	—
Prednisone, B.P. ................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Promethazine Hydrochloride, B.P.	—
Riboflavine, B.P. ................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D.
Senna Fruit, B.P. ................	—
Silver Nitrate, Toughened, B.P. .......	—
Sobee ........................	—
Sodium Lactate .................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
	Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
	Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
	Sodium Lactate with Sodium Chloride B.P.
	Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate B.P.C.	Compound Effervescent Powder, B.P.C.
Sodium Tauroglycocholate B.P.C. 1954	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C. .............	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Sulphacetamide, B.P.C. ............	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphadimethoxine, B.P.C. ..........	—
Sulphafurazole, B.P. ..............	—
Sulphamerazine, B.P. 1958 ..........	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphamethoxydiazine .............	—
Sulphamethoxypyridazine N-Acetyl	—
Sulphaphenazole, B.P.C. ...........	—
Sulphathiazole, B.P.C. .............	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement .................	—
Tacrine .......................	Morphine Sulphate B.P. with Tacrine
Tetanus Vaccine, B.P. .............	Diphtheria and Tetanus Vaccine B.P.
	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride, B.P. ......	Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline ...................	Tetracycline with a buffering agent and Amphotericin B.
	Tetracycline with a buffering agent and Nystatin B.P.
	Tetracycline with Oleandomycin
Thenalidine ....................	Thenalidine with Calcium Lactobionate
Thenalidine Tartrate ..............	Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobromine, B.P.C. ..............	Theobromine B.P.C. with Phenobarbitone B.P.
Tragacanth (Gum Karaya) ..........	—
Trimeprazine Tartrate, B.P.C. ........	—
Triprolidine Hydrochloride, B.P.C.	—
Velactin ......................	—
Viomycin Pantothenate ............	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P. ...........	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Embonate .............	—
Vitamin A .....................	Vitamins A and D Concentrated Solution
	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D .....................	Vitamins A and D Concentrated Solution
	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE.

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia.

Acetarsol Diethylamine.

Acetazolamide Sodium.

Acetic Acid, Glacial, B.P.C.

Acetohexamide.

Acidified Golden Syrup, A.P.F.

Acriflavine, B.P.C.

Acrylic Resin.

Adrenaline Hydrochloride.

Adrenaline Mucate.

Agar B.P.C. 1954.

Alkavervir.

Aloin B.P.C.

Almond Oil Volatile Bitter, B.P.C. 1959

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.

Aluminium Powder, B.P.C.

Amaranth Solution, A.P.F.

Amaranth Solution, B.P.C.

Amidopyrine, B.P.C. 1954.

Ammonia Aromatic Spirit, B.P.C.

Ammonia Solution Strong, B.P.C.

Ammonia Solution Weak, B.P.C.

Ammonium Bicarbonate, B.P.C.

Ammonium Bromide, B.P.C.

Amphotericin B.

Ampicillin.

Antazoline Methanesulphonate, B.P.C.

Antazoline Sulphate.

Attapulgite.

Aurothioglucose.

Bacitracin Eye Drops.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Benzalkonium Chloride.

Benzocaine and Adrenaline Ointment, A.P.F.

Benzoinated Lard, B.P.C. 1954.

Benzoin Compound Tincture, B.P.C.

Benzoin Gum, B.P.C.

Benzoin Tincture, B.P.C.

Benzol (Commercial).

Benzylpenicillin in Oil.

Bephenium Hydroxynaphthoate, B.P.C.

Betamethasone.

Betamethasone Disodium Phosphate.

Betamethasone Phosphate.

Bismuth Glycollylarsanilate, B.P.C.

Bismuth Sodium. Tartrate, B.P.C.

Bismuth Subgallate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu, Concentrated. Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Cade Oil, B.P.C.

Caffeine and Sodium Benzoate, B.P.C. 19543.

Caffeine Citrate, B.P.C. 1959.

Cajuput Spirit, B.P. 1948.

Calamine Cream, A.P.F.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Gluconogalactogluconate.

Calcium Lactobionate.

Calcium Phosphate, B.P.C.

Calumba, Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Capsicum Ointment, B.P.C.

Capsicum Oleoresin, B.P.C.

Capsicum Tincture, B.P.C.

Carbarsone, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Chloramine, B.P.C.

Chloramphenicol Palmitate, B.P.C.

Chloramphenicol Stearate.

Chloramphenicol Succinate.

Chlorazanil Hydrochloride.

Chlorhexidine Diacetate.

Chlorhexidine Gluconate.

Chlorobenzol Disulphonamide.

Chlorotrianisene, B.P.C.

Chlorthalidone, B.P.C.

Choline Theophyllinate, B.P.C.

Cinnamon Oil, B.P.C.

Clemizole Hydrochloride.

Clemizole Tannate.

Clove, Concentrated Infusion, B.P.C. 1954.

Cloxacillin Sodium.

Coal Tar, B.P.C.

Cochineal Tincture, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Colistin.

Copper Sulphate, B.P.C.

Creosote, B.P.C. 1959.

Cudbear Tincture, A.P.F. 1947.

Curd Soap, B.P.C.

Cyclopenthiazide.

Cyclophosphamide.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine Hydrochloride.

Death Adder Antivenene.

Demecarium Bromide.

Deoxycortone Glucoside.

Desferrioxamine.

Deslanoside.

Dexamethasone Sodium Phosphate.

Dexchlorpheniramine Maleate.

Dextran.

Dextran Iron.

Dextriferron.

Dicyclomine Hydrochloride B.P.C.

Digitalis Tincture, B.P.C. 1959.

Dihydroergotamine Methanesulphonate.

Dihydromorphinone Hydrochloride, B.P.C. 1949

Dihydrostreptomycin Sulphate, B.P. 1958.

Dihydrotachysterol.

Dill Oil, B.P.C.

Dimethicone, B.P.C.

Diphenylpyraline Hydrochloride.

Dipyridamole.

Disodium Dihydrogen Versenate.

Disodium Stilboestrol Diphosphate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate Iodide.

Entsufon.

Ephedrine, B.P.C.

Ephedrine Sulphate, B.P.C. 1954.

Ergot, Liquid Extract, B.P. 1914.

Erythromycin Ethyl Succinate.

Erythromycin Glucoheptonate.

Erythromycin Lactobionate.

Erythromycin Stearate.

Ethanolamine, B.P.C.

Ethanolamine Olcate.

Ether Nitrous Spirit, B.P.C. 1959.

Ethionamide.

Ethosuximide.

Ethoxzolamide

Ethyl Biscoumacetate, B.P.C.

Ethylidene Dicoumarin.

Ethylnoradrenaline Hydrochloride.

Eucalyptol, B.P.C.

Extract of Ox Bile, B.P. 1948.

Ferric Hydroxide.

Ferrous Aminoacetosulphate.

Ferrous Carbonate Saccharated, B.P.C. 1959.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Folinic Acid.

Framycetin Sulphate.

Fusidic Acid, Diethanolamine Salt.

Fusidic Acid, Sodium Salt.

Galactomin.

Gall and Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Glucagon Hydrochloride.

Glucose Indicator.

Glycerophosphate Compound Syrup, A.P.F.

Gramicidin.

Haemophilus Influenza Bacterial Scrum.

Hamamelis Dry Extract, B.P.C.

Hamamelis Liquid Extract, B.P.C.

Heparin Retard.

Hexocyclium Methylsulphate.

Honey, Purified, B.P.C.

Hydrargaphen.

Hydrocyanic Acid, Dilute, B.P.C. 1954.

Hydroxyprogesterone Caproate.

Hyoscine Methobromide.

Hypophosphorous Acid, Dilute, B.P.C.

Insulin Injection, specially purified.

Insulin Isophane Injection, specially purified.

Insulin Injection, Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform, B.P.C. 1954.

Iron Aminoates.

Iron Oxide Saccharated.

Iron Sorbitol Complex.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride, B.P.C.

Kanamycin Sulphate, B.P.C.

Lanatoside-C.

Lavender Spike Oil, B.P.C.

Lemon Tincture, B.P. 1958.

Leptazol, B.P.C.

Lissapol.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Magnesium Chloride.

Magnesium Hydroxide, B.P.C.

Magnesium Oxide, Heavy, B.P. 1958.

Mebhydrolin Napadisylate, B.P.C.

Mecholyl Chloride.

Medroxyprogesterone Acetate.

Mercaptomerin Sodium

Mercuric Chloride, B.P.C.

Mercuric Oxide Eye Ointment, B.P.C.

Mercurous Chloride Ointment, B.P. 1948.

Mercury Compound Ointment, B.P.C. 1959.

Mestanolone.

Metaraminol Bitartrate.

Metformin Hydrochloride.

Methandriol.

Methazolamide.

Methdilazine Hydrochloride.

Methenamine Mandelate.

Methenolone Acetate.

Methenolone Oenanthate.

Methotrexate.

Methoxamine Hydrochloride, B.P.C.

Methyclothiazide.

Methyldopa.

Methyl Glucamine.

Methylphenobarbitone, B.P.C.

Metronidazole, B.P.C.

Minafen.

Mitomycin.

Myrrh Gum, Powdered, B.P.C.

Myrrh Tincture, B.P.C.

Nandrolone Decanoate.

Niclosamide.

Nicoumalone.

Tragacanth (Gum Karaya).

Tretamine.

Triamcinolone, B.P.C.

Triamterene.

Triaziquone.

Tricyclamol Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Trimeprazine Tartrate, B.P.C.

Trinitrophenol, B.P.C. 1959.

Triprolidine Hydrochloride, B.P.C.

Urea, B.P.C.

Vadrine.

Valerian Ammoniated Tincture, B.P.C.

Vanillin, B.P.C.

Vasopressin Tannate.

Velactin.

Vinblastine Sulphate.

Vinegar of Squill, B.P.C.

Viomycin Pantothenate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

Zinc Stearate, B.P.C.

FOURTH SCHEDULE.

Regulation 12.

Additives.

Acetone, B.P.C.

Alcohol (95%), B.P.

Dilute Alcohols, B.P.

Amethocaine Hydrochloride, B.P.

Bacitracin, B.P.

Caraway Oil, B.P.C.

Carmine Solution, A.P.F.

Citronella Oil, B.P.C.

Cod Liver Oil, B.P.

Xylene, B.P.C. 1949.

FIFTH SCHEDULE.

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Acetylsalicylic Acid Tablets, B.P. .....		Any disease or condition in a pensioner
Soluble Acetylsalicylic Acid Tablets, B.P.
Compound Acetylsalicylic Acid Tablets, A.P.F.
Compound Acetylsalicylic Acid Tablets, B.P.C.
Soluble Compound Acetylsalicylic Acid Tablets
Acrylic Rosin ...................	Ileostomy or colostomy conditions
Alkavervir .....................	Hypertensive crises
Amphotericin B .................	Systemic fungal infection

Ampicillin .....................	with the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic
Aneurine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner
Ascorbic Acid Tablets, B.P. .........	Any disease or condition in a pensioner
Bemegride Injection, B.P. ...........	As an antidote to barbiturate and other hypnotic poisons
Benzol (Commercial) .............	Ileostomy or colostomy conditions
Betamethasone Tablets ............	With the written authority of the Director-General a disease or condition specified in this column in relation to Prednisolone Tablets

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Busulphan Tablets, B.P. ........	Leukaemia
Calciferol Tablets, B.P. ........	Any disease or condition in a pensioner.
	With the written authority of the Director-General—
	Hypoparathyroidism
	Chronic hypoparathyroid tetany
	Vitamin D-resistant rickets
Calciferol Solution, B.P. ........	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Aminosalicylate .......	Tuberculosis
Calcium Gluconogalacto-gluconate Effervescent Tablets	Hypoparathyroidism
Caramiphen Tablets, B.P. .......	Parkinsonism
Chlorambucil Tablets, B.P. ......	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P. ..	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
	Bacterium coli meningitis, if other forms of treatment are unsuccessful
	Granuloma inguinale
	Friedlander bacillus infections
	Haemophilus influenza infections
	Lymphogranuloma venereum
	Salmonella infections
	Staphylococcal infections
	Typhoid fever
	Typhus and other rickettsial diseases
	Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
Chloramphenicol Injections .....	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets .......
Chloramphenicol Oral Suspension	A disease or condition specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlorotrianisene Tablets ........	Carcinoma of the prostate
Chlorpheniramine Maleate Syrup	Any disease or condition in a child under the age of twelve years
Chlorpromazine Hydrochloride ...	Any disease or condition in a pensioner
	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
	Late-stage malignancy
	Radiation sickness
	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride
Chlortetracycline Capsules, B.P. ..	As an alternative to the Penicillins in a person sensitive to the Penicillins
	Actinomycosis
	Amoebiasis

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chlortetracycline Capsules, B.P.—continued.	Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
	Bronchiectasis
	Brucellosis
	Chancroid
	Fibrocystic disease of the pancreas
	Granuloma inguinale
	Friedlander bacillus infections
	Leptospirosis
	Lymphogranuloma venereum
	Muscoviscidosis
	Pneumonia that is resistant both to the Penicillins and the Sulphonamides
	Pre-operative prophylaxis
	Primary atypical pneumonia
	Psittacosis
	Puerperal infections
	Rat-bite fever (Spirillum minus)
	Staphylococcal infections
	Trachoma that is resistant to the Sulphonamides
	Typhus and other rickettsial diseases
	Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
	Whooping cough (Haemophilus pertussis)
Chlortetracycline Hydrochloride Granules	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child
	under the age of twelve years
Choline Theophyllinate ..........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Clemizole Tannate Syrup .........	Any disease or condition in a child under the age of twelve years
Cloxacillin Sodium .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Compound Codeine Tablets, B.P. ...		Any disease or condition in a pensioner
Compound Codeine Soluble Tablets, B.P.
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid Tablets
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets
Cod Liver Oil ................	Any disease or condition in a child under the age of twelve years or in a pensioner
Cod Liver Oil Emulsion ..........
Colistin ....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
Corticotrophin Injection, B.P. ......	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection, B.P.
	Hypsarrhythmia
Corticotrophin Zinc Hydroxide Injection, B.P.	Salaam convulsions
	The prevention of side effects of corticosteroid therapy

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Injection, B.P. .........	With the written authority of the Director-General—
	Anaemia, acquired haemolytic
	Addison’s disease or other forms of adrenocortical hypoplasia
	Adrenalectomy, total
	Adrenogenital syndrome
	Agranulocytosis
	Behcet’s syndrome
	Cranial arteritis
	Cushing’s syndrome, including hyperadrenocorticalism
	Dermatitis, acute exfoliative
	Dermatomyositis
	Encephalomyelitis
	Encephalomyelitis, acute disseminated
	Guillain-Barré syndrome
	Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
	Hansen’s disease
	Hepatitis, progressive or continuing, proven by biopsy or biochemistry
	Hodgkin’s disease
	Idiopathic hypercalcaemia
	Keratoplasty
	Leucine-sensitive hypoglycaemia
	Leukaemia
	Lymphosarcoma and follicular lymphoma
	Metastatic breast cancer
	Nephrosis or nephrotic syndrome
	Neuro-myelitis optica
	Optic neuritis following removal of tumor of the brain
	Panhypopituitarism
	Pemphigus
	Periarteritis nodosa
	Progressive transverse myelitis
	Pseudohermaphroditism
	Purpura, Henoch’s
	Purpura, thrombocytopenic
	Reticulum cell sarcoma
	Rheumatic carditis, acute
	Sarcoidosis
	Scleroderma
	Severe reactions of the skin and mucosa following X-ray therapy
	Splenic neutropenia
	Status asthmaticus
	Steroid therapy prior to operation in patients under steroid therapy
	Stevens-Johnson syndrome
	Still’s disease in a child under the age of sixteen years
	Sympathetic ophthalmitis
	Systemic lupus erythematosus
	Temporal arteritis
	Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
	Type II Nephritis
	Ulcerative colitis proven by sigmoidoscopy or radiological report
	Uveitis, posterior

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Tablets, B.P. ............	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection, B.P. (other than 1,000 microgramme strength)	Established megalocytic anaemia
Cyanocobalamin Injection, B.P. (1,000 microgramme strength)	Neuroblastoma
Cyanocobalamin Injection, B.P. (1,000 microgramme strength)	Subacute combined degeneration of the cord
Cymogran .....................	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P. ................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine Capsules, B.P. ..........
Cyproheptadine Hydrochloride Syrup	Any disease or condition in a child under the age of twelve years
Demethylchlortetracycline Capsules, B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension	Any disease or condition specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections	Addison’s disease Adrenalectomy, total
Deoxycortone Acetate Injection, B.P.
Deoxycortone Trimethylacetate Injection, B.P.
Deoxycortone Acetate Implants, B.P.
Deoxycortone Acetate Tablets
Desferrioxamine .................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P. ........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexchlorpheniramine Maleate Syrup	Any disease or condition in a child under the age of twelve years
Dextran with Dextrose .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dextran in Normal Saline ...........
Dicyclomine Hydrochloride Syrup	Any disease or condition in a child under the age of twelve years
Dienoestrol Cream ...............	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P. ...........	Carcinoma of the prostate
	Mammary carcinoma
	Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol ...............	Parathyroid deficiency
Diiodohydroxyquinoline Vaginal Tablet	Trichomonal or monilial vaginitis
Diiodohydroxyquinoline Effervescent Gynaecological Pessary	Trichomonal or monilial vaginitis
Diloxanide Furoate Tablets, B.P. ......	Amoebic dysentery
Dimethicone ...................	Ileostomy or colostomy conditions
Diphenhydramine Hydrochloride Elixir	Any disease or condition in a child under the age of twelve years
Disodium Stilboestrol Diphosphate	Carcinoma of the prostate
Ditophal ......................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Ephedrine Hydrochloride with Phenobarbitone Elixir	Any disease or condition in a child under the age of twelve years
Erythromycin Capsules ............		A disease or condition specified in this column in relation to Chlortetracycline Capsules
Erythromycin Tablets .............
Erythromycin Injections ............
Erythromycin, Oral Sachet ..........		A disease or condition specified in this column in relation to Chlortetracycline Capsules in a child under the age of twelve years
Erythromycin, Oral Suspension .......
Ethinyloestradiol Tablets, B.P. .......	Turner’s syndrome
	Pre-menopausal castration syndrome
	Any disease or condition in a pensioner
Ethionamide ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethisterone Tablets, B.P. ...........	Turner’s syndrome
Ethosuximide Syrup ..............	Any disease or condition in a child under the age of twelve years
Ferric Hydroxide Colloidal Solution
Ferrous Aminoacetosulphate Syrup	Any disease or condition in a child under the age of twelve years
Ferrous Gluconate Elixir ...........
Ferrous Succinate Elixir ............
Ferrous Sulphate Oral Drops .........
Fludrocortisone Tablets, B.P. ........	Addison’s disease
Fluoxymesterone Tablets, B.P. .......	Mammary carcinoma
	With the written authority of the Director-General, long-term corticosteroid therapy
Folic Acid Injection ..............	Macrocytic anaemia
Folic Acid Tablets, B.P. ............	Sprue or the sprue-like syndrome
Folinic Acid ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Fusidic Acid (Sodium Salt or Diethanolamine Salt)
Galactomin ....................	With the written authority of the Director-General, galactosaemia
Griseofulvin Tablets, B.P. ..........	With the written authority of the Director-General—
	For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report—
	Epidermophyton floccosum
	Microsporum audouini
	Microsporum canis
	Microsporum gypseum
	Trichophyton interdigitale
	Trichophyton mentagrophytes
	Trichophyton rubrum
	Trichophyton schoenleini
	Trichophyton sulphureum
	Trichophyton verrucosum
Halibut Liver Oil Capsules ..........	Any disease or condition in a pensioner
Haemophilus Influenza Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophane with Entsufon ......
Hexachlorophane with Lissapol .......
Hexachlorophane in Soap Solution
Hydrocortisone Injection ...........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
	Stevens-Johnson syndrome

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Hydrocortisone Sodium Succinate Soluble Tablet	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydroxocobalamin Injection, B.P. (100 microgramme strength)	Established megalocytic anaemia
Hydroxocobalamin Injection, B.P. (1,000 microgramme strength)	Neuroblastoma
	Sub-acute combined degeneration of the cord
Hydroxyprogesterone Caproate ..	Habitual abortion
Isoniazid Tablets, B.P. ........	Hansen’s disease
	Tuberculosis
Kanamycin Sulphate .........	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Levorphanol Tartrate .........	Obstetrical use
	Severe intractable pain
Liothyronine Sodium .........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Liothyronine Tablets, B.P. ......
Lofenalac .................	With the written authority of the Director-General, phenylketonuria
Mebhydrolin Napadisylate Oral Suspension	Any disease or condition in a child under the age of twelve years
Medroxyprogesterone Acetate ...	Any disease or condition in a patient receiving treatment in or at an approved hospital
Mepyramine Maleate Elixir .....	Any disease or condition in a child under the age of twelve years
Mercaptopurine Tablets, B.P. ....	Allergic angiitis
	Leukaemia
	Lupus erythematosus
	Periarteritis
Mestanolone ...............	Mammary carcinoma
	With the written authority of the Director-General, long-term corticosteroid therapy
Methandienone Tablets, B.P. ....	Mammary carcinoma
	With the written authority of the Director-General, long-term corticosteroid therapy
Methandriol ...............	Senile osteoporosis proven by radiological report
	With the written authority of the Director-General, long-term corticosteroid therapy
Methdilazine Hydrochloride Syrup	Any disease or condition in a child under the age of twelve years
Methenolone Acetate .........	Senile osteoporosis proven by radiological report
	With the written authority of the Director-General, long-term corticosteroid therapy
Methenolone Oenanthate ......	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Sodium ..........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P. ......
Methotrexate ..............	Leukaemia and neo-plastic disease
Minafen ..................	With the written authority of the Director-General, phenylketonuria
Mitomycin ................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Morphine with Tacrine Tablets ...	Severe intractable pain
Mustine Injection, B.P. ........	Malignant lymphoma and related conditions
Nandrolone Phenyl-propionate Injection B.P.	Mammary carcinoma
Nandrolone Phenyl-propionate Injection B.P.	With the written authority of the Director-General, long-term corticosteroid therapy
Nandrolone Decanoate ........
Neomycin Sulphate Tablets .....	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Nicotinamide Tablets ............	Any disease or condition in a pensioner
Nicotinic Acid Tablets, B.P. ........	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P. ........	Urinary tract infections
Nitrofurantoin Oral Suspension ......	Any urinary tract infection in a child under the age of twelve years
Nitromin .....................	Malignant lymphoma and related conditions
Norethandrolone ...............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Norethandrolone Tablets, B.P. ......
Novobiocin Calcium .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium .............
Novobiocin Tablets, B.P. ..........
Nystatin .....................	Proven monilia infections
Orciprenaline Sulphate ...........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxymesterone .................	Senile osteoporosis proven by radiological report
	With the written authority of the Director-General, long-term corticosteroid therapy
Oxytetracycline Hydrochloride Capsules	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Tablets, B.P. .......
Oxytetracycline Hydrochloride Injections
Calcium di-Oxytetracycline Oral Suspension	A disease or condition specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Calcium di-Oxytetracycline Paediatric Drops
Oxytocin Nasal Spray ............	Induction of labour
Pancreatin B.P. ................	Fibrocystic disease
Pancreatin B.P. ................	Pancreatico-duodenectomy
Pancreatin Enzyme U.S.N.F. XI .....	Pancreatico-duodenectomy
Pancreatin Enzyme U.S.N.F. XI .....	Pancreatic steatorrhoea
Para-Aminosalicylic Acid .........	Tuberculosis
Paracetamol Oral Suspension .......	Any disease or condition in a child under the age of twelve years
Paramethasone Acetate ...........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion ..........	Any disease or condition in a pensioner
Paraffin Liquid Emulsion with Phenolphthalein	Any disease or condition in a pensioner
Penicillamine .................	With the written authority of the Director-General, Wilson’s disease
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
Phenoxymethylpenicillin, Oral Suspensions	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin, Oral Sachets
Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Benzylpenicillin with Procaine Pencillin and Streptomycin Sulphate
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Pheniramine Maleate Syrup ........	Any disease or condition in a child under the age of twelve years
Phenytoin ....................	Any disease or condition in a child under the age of twelve years
Phytomenadione Injection, B.P. .....	Antidote to anticoagulants
Piperazine Citrate Elixir ..........	Any disease or condition in a child under the age of twelve years

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Prednisolone Sodium Phosphate Retention Enema	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets, B.P. ..........	With the written authority of the Director-General—
	Inflammatory conditions of the uveal tract and retina
	Nodular non-suppurative panniculitis (Christian-Weber disease)
	A disease or condition specified in this column in relation to Cortisone Injection except Total adrenalectomy, Addison’s disease or other forms of adrenocortical hypoplasia
Methylprednisolone Tablets, B.P. .....	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Methylprednisolone Capsules ........
Prednisolone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets, B.P. ...........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Progesterone ...................	Habitual abortion
Promethazine Hydrochloride Elixir	Any disease or condition in a child under the age of twelve years.
Protoveratrine A .................	Hypertensive crises
Pyrazinamide ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridine Aldoxime Methiodide .......	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection, B.P. ........	Myasthenia gravis
Pyridostigmine Tablets, B.P. .........	Myasthenia gravis
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy
	Radiation sickness
Quinethazone ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Riboflavine Tablets ...............	Any disease or condition in a pensioner
Ristocetin .....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Senna Fruit Extract (Standardized)	Any disease or condition in a pensioner
Sobee ........................	With the written authority of the Director-General—
	Galactosaemia
	Lactose intolerance
	Milk allergy
Sodium Aminosalicylate ...........	Tuberculosis
Sodium Folate ..................	Macrocytic anaemia
	Sprue or the sprue-like syndrome
Spiramycin ....................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Spironolactone ..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Stanolone .....................	Mammary carcinoma
	With the written authority of the Director-General, long-term corticosteroid therapy

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Stilboestrol Injection ..............	Carcinoma of the prostate Mammary Carcinoma Any disease or condition in a pensioner
Stilboestrol Tablets, B. P. ...........
Streptomycin Sulphate Injections ......	Bacillary dysentery that is resistant to the Sulphonamides
	Brucellosis
	Chancroid
	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
	Friedlander bacillus infections
	Haemophilus influenza infections
	Plague
	Pseudomonas pyocyanea infections
	Rat-bite fever (Streptobacillus moniliformis)
	Salmonella infections
	Surgical conditions of the bowel (pre-operative and post-operative)
	Surgical conditions of the thoracic organs
	Tuberculosis
	Tularaemia
	Urinary tract infections that are resistant to the Sulphonamides
Sulphadimethoxine Oral Suspension	Any disease or condition in a child under the age of twelve years
Sulphadimidine Oral Suspension ......
Sulphamethoxydiazine Oral Suspension
Sulphamethoxypyridazine N-Acetyl Oral Suspension
Sulphaphenazole Oral Suspension
Sulphasalazine ..................	Ulcerative colitis
Sultiame ......................	For use where other anticonvulsants have failed
Surgical Cement .................	Ileostomy or colostomy conditions
Sustanon ......................	Castration syndrome (male and female) Klinefelter Reifenstein Albright syndrome Mammary carcinoma
Testosterone Implants, B.P. .........
Testosterone Oenanthate ...........
Testosterone Propionate Injection, B.P.
Testosterone Propionate Implants
Methyltestosterone Tablets, B.P. ......
Tetracycline Capsules, B.P. .........	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets, B.P. ...........
Tetracycline Injections .............
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection
Tetracycline with Oleandomycin Capsules and Injection
Rolitetracycline .................
Tetracycline Granules .............	A disease or condition specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Tetracycline Paediatric Drops ........
Tetracycline Oral Suspension ........
Tetracycline with a buffering agent—Paediatric Drops
Tetracycline with a buffering agent—Oral Suspension
Tetracycline with Oleandomycin Oral Sachet
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline with Oleandomycin Paediatric Drops

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Tetracycline with a buffering agent and Nystatin in a child under the age of twelve years
Tetracycline with a buffering agent and Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thenalidine with Calcium Lactobionate Syrup	Any disease or condition in a child under the age of twelve years
Theophylline Elixir ............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Thioridazine Tablets, B.P. .......	Any disease or condition in a pensioner
	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
	Late-stage malignancy
	Radiation sickness
	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride
Thiotepa ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Thyrotrophin ................
Tragacanth (Gum Karaya) .......	Ileostomy or colostomy conditions
Tretamine ..................	Malignant lymphoma and related conditions
Triamcinolone ...............	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Triamterene ................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triaziquone .................
Trifluoperazine Tablets, B.P. .....	Any disease or condition in a pensioner
	Any disease or condition in a patient receiving treatment in or at an approved hospital
	With the written authority of the Director-General—
	Late-stage malignancy
	Radiation sickness
	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act,
Trimeprazine Tartrate Syrup .........	Any disease or condition in a child under the age of twelve years
Trimetaphan Injection, B.P. .........	Hypotensive for anaesthesia
Triprolidine Hydrochloride Elixir. .....	Any disease or condition in a child under the age of twelve years
Vadrine ......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vancomycin Hydrochloride .........
Velactin ......................	With the written authority of the Director-General—
	Galactosaemia
	Lactose intolerance
	Milk allergy
Vinblastine Sulphate ..............	Hodgkin’s disease
Viomycin Sulphate ...............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate Injection B.P. .....
Viomycin Sulphate with Viomycin Pantothenate Combination	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner
Vitamin A Tablets or Capsules .......	Any disease or condition in a pensioner
Concentrated Vitamin A Solution	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution
Concentrated Vitamin D Solution	Tetany
	Any disease or condition in a child under the age of twelve years or in a pensioner

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.